ToxReporter: viewing the genome through the eyes of a toxicologist

Mark Gosink1

  • 1Department of Investigative Toxicology, Pfizer Inc, Eastern Point Rd, MS 8274-1246, Groton, CT 06340, USA Mark.M.Gosink@Pfizer.com.

Insights

ToxReporter streamlines toxicological research by compiling gene and protein safety data from diverse sources. This tool helps toxicologists efficiently identify potential adverse event links by filtering and ranking information based on user-defined safety categories.

Area of Science:

  • Toxicology
  • Bioinformatics
  • Computational Biology

Background:

  • Toxicologists investigate adverse events (AEs) by searching extensive databases for gene/protein links.
  • Current databases can be overwhelming, hindering the identification of specific toxicity information.
  • Efficiently linking AEs to specific gene functions is crucial for toxicological assessment.

Purpose of the Study:

  • To develop ToxReporter, a web-application designed to streamline the process of identifying gene/protein-related adverse events.
  • To provide toxicologists with a tool that filters and categorizes safety information based on user-defined criteria.
  • To enhance the efficiency of toxicological research by presenting relevant data in an accessible format.

Main Methods:

  • ToxReporter is a PERL-based web application utilizing a MySQL database.
  • It categorizes public and proprietary data into predefined safety categories using a customizable lexicon.
  • A scoring system ranks genes based on the frequency of 'red-flagged' information relevant to specific safety issues.

Main Results:

  • ToxReporter compiles and filters information from multiple resources, focusing on user-selected areas of interest.
  • It 'red-flags' gene information pertinent to the investigated safety issue.
  • A 'Tox-At-A-Glance' chart provides an easily interpretable ranking of genes based on safety information.

Conclusions:

  • ToxReporter effectively consolidates and presents complex safety data, aiding toxicologists in AE investigations.
  • The tool's flexible design allows for adaptation to other data types, such as disease information.
  • ToxReporter offers a valuable solution for managing and interpreting large-scale biological safety data.

Related Concept Videos

Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
99
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
92
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.1K
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
75
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
114
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
122